Search research articles
Contact Us
Filters
Showing results (31-40 of 149) with videos related to
Page
of 15
Sort By:
The Senior Care Pharmacist
|
January 1, 2021
Tacrolimus-Induced Bradykinesia Secondary to Phenoconversion in an Elderly Post-Bilateral Lung Transplant Patient
Lia Argevani, Michael J Schuh, Sheena Crosby
The Senior Care Pharmacist
|
December 4, 2021
Implications of Cannabidiol in Pharmacogenomic-Based Drug Interactions with CYP2C19 Substrates
Anastasia Engeleit, Sheena Crosby, Michael J Schuh
Journal of Pain & Palliative Care Pharmacotherapy
|
March 19, 2020
Improving Pain Management with Pharmacogenomics: A General Introduction
Michael J Schuh, Heather Randles, Sheena Crosby
Innovations in Pharmacy
|
May 19, 2021
Dosage Adjustment of Irinotecan in Patients with UGT1A1 Polymorphisms: A Review of Current Literature
Lia Argevani, Caren Hughes, Michael J Schuh
Biomedica Biochimica Acta
|
January 1, 1987
[Ontogenetic changes in the circadian rhythm of plasma insulin and its correlation to food intake]
D Weinert, F E Ulrich, J Schuh
Innovations in Pharmacy
|
May 23, 2022
Tacrolimus Therapeutic Drug Monitoring in Kidney Transplant Patients Before and After Pharmacist Post-transplant Consults
Gabriella Massoglia, Murraysha Ramnarine, Michael J Schuh
Innovations in Pharmacy
|
November 29, 2023
High-Evidence, Actionable Phenotype Gene Distribution in a Multispecialty, Tertiary Care Clinic: Potentially Actionable Genes and a Referring Department Profile
Blake Bartlett, Sheena Crosby, Michael J Schuh
Innovations in Pharmacy
|
June 12, 2023
Phenytoin Toxicity with High Dose, Concomitant Ascorbic Acid Dosing
Michael J Schuh, Kevin Mustain, Sheena Crosby
The Consultant Pharmacist : the Journal of the American Society of Consultant Pharmacists
|
June 2, 2011
Building a pharmacist-managed pharmacotherapy medication therapy management practice
Michael J Schuh, Deborah J Crumb, Jason Dubois
Innovations in Pharmacy
|
January 11, 2023
Hyponatremic Cognitive Dysfunction Resulting from Drug-Drug-Gene Interaction between Sertraline and Cannabidiol in an Intermediate CYP2C19 Metabolizer Patient
Jade Camara Nanan, Sheena Crosby, Michael J Schuh
Page
of 15
Search research articles
Search
Showing results (31-40 of 149) with videos related to
Sort By:
Page
of 15
The Senior Care Pharmacist
|
January 1, 2021
Tacrolimus-Induced Bradykinesia Secondary to Phenoconversion in an Elderly Post-Bilateral Lung Transplant Patient
Lia Argevani, Michael J Schuh, Sheena Crosby
The Senior Care Pharmacist
|
December 4, 2021
Implications of Cannabidiol in Pharmacogenomic-Based Drug Interactions with CYP2C19 Substrates
Anastasia Engeleit, Sheena Crosby, Michael J Schuh
Journal of Pain & Palliative Care Pharmacotherapy
|
March 19, 2020
Improving Pain Management with Pharmacogenomics: A General Introduction
Michael J Schuh, Heather Randles, Sheena Crosby
Innovations in Pharmacy
|
May 19, 2021
Dosage Adjustment of Irinotecan in Patients with UGT1A1 Polymorphisms: A Review of Current Literature
Lia Argevani, Caren Hughes, Michael J Schuh
Biomedica Biochimica Acta
|
January 1, 1987
[Ontogenetic changes in the circadian rhythm of plasma insulin and its correlation to food intake]
D Weinert, F E Ulrich, J Schuh
Innovations in Pharmacy
|
May 23, 2022
Tacrolimus Therapeutic Drug Monitoring in Kidney Transplant Patients Before and After Pharmacist Post-transplant Consults
Gabriella Massoglia, Murraysha Ramnarine, Michael J Schuh
Innovations in Pharmacy
|
November 29, 2023
High-Evidence, Actionable Phenotype Gene Distribution in a Multispecialty, Tertiary Care Clinic: Potentially Actionable Genes and a Referring Department Profile
Blake Bartlett, Sheena Crosby, Michael J Schuh
Innovations in Pharmacy
|
June 12, 2023
Phenytoin Toxicity with High Dose, Concomitant Ascorbic Acid Dosing
Michael J Schuh, Kevin Mustain, Sheena Crosby
The Consultant Pharmacist : the Journal of the American Society of Consultant Pharmacists
|
June 2, 2011
Building a pharmacist-managed pharmacotherapy medication therapy management practice
Michael J Schuh, Deborah J Crumb, Jason Dubois
Innovations in Pharmacy
|
January 11, 2023
Hyponatremic Cognitive Dysfunction Resulting from Drug-Drug-Gene Interaction between Sertraline and Cannabidiol in an Intermediate CYP2C19 Metabolizer Patient
Jade Camara Nanan, Sheena Crosby, Michael J Schuh
Page
of 15